192 related articles for article (PubMed ID: 12352935)
1. Does lamotrigine influence valproate concentrations?
Mataringa MI; May TW; Rambeck B
Ther Drug Monit; 2002 Oct; 24(5):631-6. PubMed ID: 12352935
[TBL] [Abstract][Full Text] [Related]
2. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
[TBL] [Abstract][Full Text] [Related]
4. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
5. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
[TBL] [Abstract][Full Text] [Related]
6. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
7. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
8. Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.
Yamamoto Y; Inoue Y; Matsuda K; Takahashi Y; Kagawa Y
Biol Pharm Bull; 2012; 35(4):487-93. PubMed ID: 22466551
[TBL] [Abstract][Full Text] [Related]
9. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
Gidal BE; Sheth R; Parnell J; Maloney K; Sale M
Epilepsy Res; 2003 Dec; 57(2-3):85-93. PubMed ID: 15013050
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
[TBL] [Abstract][Full Text] [Related]
12. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
13. Influence of uridine diphosphate glucuronosyltransferase inducers and inhibitors on the plasma lamotrigine concentration in pediatric patients with refractory epilepsy.
Yamamoto Y; Takahashi Y; Imai K; Ikeda H; Takahashi M; Nakai M; Inoue Y; Kagawa Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):214-20. PubMed ID: 25825021
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.
Baldoni AO; Freitas-Lima P; de Santi Ferreira FI; Martinez EZ; Queiroz RH; Sakamoto AC; Alexandre V; Perucca E; Pereira LR
Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):685-9. PubMed ID: 27120710
[TBL] [Abstract][Full Text] [Related]
15. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response.
Bartoli A; Guerrini R; Belmonte A; Alessandrì MG; Gatti G; Perucca E
Ther Drug Monit; 1997 Jun; 19(3):252-60. PubMed ID: 9200763
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.
Brodie MJ; Yuen AW
Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
[TBL] [Abstract][Full Text] [Related]
20. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction.
Kanner AM; Frey M
Neurology; 2000 Aug; 55(4):588-91. PubMed ID: 10953201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
